2013
DOI: 10.3892/mco.2013.109
|View full text |Cite
|
Sign up to set email alerts
|

Investigation of free cancer cells in peripheral blood using CEA mRNA expression in perioperative colorectal cancer patients

Abstract: The aim of this study was to evaluate the impact of laparoscopic surgery (Lap) on circulating free tumor cells in colorectal cancer patients. In this study, we selected carcinoembryonic antigen (CEA) mRNA expression in peripheral blood as the marker of the circulating tumor cells and compared this marker between Lap and open colectomy (OC), to investigate differences due to surgical approach. A total of 50 patients underwent curative surgery for solitary colorectal cancer at our department, between June, 2008 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…In one study, CEA mRNA levels increased immediately after surgery, but fell to pre-operative levels, 19 and no differences in outcome could be detected between the open and laparoscopic surgery groups. The association with rectal cancer is hypothesised to be due to the complexity of surgery and longer dissection distance with rectal cancers, or perhaps to a difference in biology of rectal cancer.…”
Section: Ctcs and Ctna Dissemination In Non-metastatic Surgerymentioning
confidence: 92%
“…In one study, CEA mRNA levels increased immediately after surgery, but fell to pre-operative levels, 19 and no differences in outcome could be detected between the open and laparoscopic surgery groups. The association with rectal cancer is hypothesised to be due to the complexity of surgery and longer dissection distance with rectal cancers, or perhaps to a difference in biology of rectal cancer.…”
Section: Ctcs and Ctna Dissemination In Non-metastatic Surgerymentioning
confidence: 92%